Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
Vera Therapeutics announced the planned retirement of Chief Regulatory Officer William Turner, who will transition to a Strategic Advisor role in Q3 2026. Dr. Nancy Boman, formerly CRO at Kyverna Therapeutics and with prior experience at Novartis, Amgen, and Genentech, will succeed him as CRO.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.